TRIBUNJOGJA.COM -Pandemic Corona virus cause COVID-19 still facing the world. Until now there has been no virus vaccine that causes pneumonia.
Experts from various countries continue to test Coronavirus vaccine, even those produced by Indonesia.
Hundreds of candidates for the corona vaccine are still under development and most have entered phase II and phase III vaccine testing.
One vaccine candidate that stole the attention of researchers is that developed by a biotechnology company from the United States, Moderna.
As quoted Kompas.com from South China Morning Post (SCMP), Wednesday (07/15/2020), experimental vaccine Modern Inc. for COVID-19, in the early stages of the study proved safe and able to trigger an immune response in 45 healthy volunteers.
The report submitted on Tuesday (07/14/2020) did not show any side effects felt by the volunteers who received the test Coronavirus vaccine this.
However, more than half of these volunteers reported mild or moderate reactions.
The research team reported in the New England Journal of Medicine, this may occur after the second dose and in people who get the highest dose.
Moderna was the first to begin testing a new corona virus vaccine, SARS-CoV-2, in humans. This test was carried out on March 16, about 66 days after the viral genome sequence was released.
• Domestic Covid-19 Vaccine Targeted Can Be Produced Early in 2021, Said President Jokowi
How vaccines work on the body
–
